Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mirror, mirror, in the hand: could a simple trick boost stroke recovery?

NCT ID NCT06103045

Symptom relief Sponsor: National Taiwan University Hospital Hsin-Chu Branch Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using a mirror to create the illusion of movement in a paralyzed arm can improve function in people who had a stroke within the past month. 49 participants were split into three groups: one did mirror therapy with only the good arm moving, another moved both arms, and a third received standard occupational therapy. All groups had 20 sessions over 4 weeks, and researchers measured arm movement, strength, and daily activity before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mirror therapy (unilateral and bilateral)
What this could lead to
If successful, this could point toward a simple, low-cost therapy to improve arm movement after a stroke.
What could go wrong
This is a small pilot study (49 people) with no blinding, so results may not be reliable or generalizable. The therapy is not a cure and only aims to ease symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

49 people

The number who actually took part.

Started

Feb 2023

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Unilateral stroke onset within 1 month * The score of Mini-Mental State Examination (MMSE) is more than 24 * The score of Fugl-Meyer Assessment for upper extremity (FMA-UE) is between 18 to 56 * The score of Modified Ashworth Scale (MAS) is less than 3 * Willing to receive 3-5 sessions of the intervention per week, total 20 sessions consecutively * Willing to sign informed consent Exclusion Criteria: * Unstable vital sign or complicating with other symptoms of neurological disease * Auditory or visual function impairment * Complicating with perceptual impairment (e.g., apraxia, neglect, or visual agnosia) * Receiving botulinum toxin injection within 3 months * Complicating with Wernicke's or Broca's aphasia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke (subacute) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke (subacute)

Contacts and locations

Locations

  • National Taiwan University Hospital Hsin-Chu Branch

    Hsinchu, 300, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.